Prognostic value of automated KI67 scoring in breast cancer
Mustapha Abubakar,
Nick Orr,
Frances Daley,
Penny Coulson,
H Raza Ali,
Fiona Blows,
Javier Benitez,
Roger Milne,
Herman Brenner,
Christa Stegmaier,
Arto Mannermaa,
Jenny Chang-Claude,
Anja Rudolph,
Peter Sinn,
Fergus J Couch,
Peter Devilee,
Rob AEM Tollenaar,
Caroline Seynaeve,
Jonine Figueroa,
Mark E Sherman,
Jolanta Lissowska,
Stephen Hewitt,
Diana Eccles,
Maartje J Hooning,
Antoinette Hollestelle,
John WM Martens,
Carolien HM van Deurzen,
kConFab Investigators,
Manjeet K Bolla,
Qin Wang,
Michael Jones,
Minouk Schoemaker,
Jelle Wesseling,
Flora E van Leeuwen,
Laura van 't Veer,
Douglas Easton,
Anthony J Swerdlow,
Mitch Dowsett,
Paul D Pharoah,
Marjanka K Schmidt,
Montserrat Garcia-Closas
May 02, 2019
BACKGROUND: The value of KI67 in breast cancer prognostication has been questioned due to concerns on the analytical validity of visual KI67 assessment and methodological limitations of published studies. Here, we investigate...